CRL

Charles River Laboratories

Halal Rating :
Uncomfortable
See Details
Last Price $233.50 Last updated:
Market Cap $11.96b
7D Change 1.95%
1 Year Change 23.23%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Commercial Services
  • Miscellaneous Commercial Services
Exchange NYSE
Next Earnings Date Feb. 14, 2024

Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $1.0b $537.29m $1.59m $33.54m 0.16% 6.24%
Sept. 30, 2023 $1.02b $462.48m $1.37m $33.74m 0.14% 7.30%
June 30, 2023 $1.05b $479.22m $1.43m $35.04m 0.14% 7.31%

Company Impact

Help us evaluate Charles River Laboratories's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Justification for our Halal Rating

Contribute

Recent News & Updates